Dorsey Brian
Insider CIK 1380762 · APRI SVP, Chief Development Officer · PTX SVP, Research · SOMX SVP, Technical Operations · SPRY Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-11-13 | 2025-11-14 | 21,828 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-11-13 | 2025-11-14 | 21,828 | $8.71 | $190.1K | 10,789 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-11-13 | 2025-11-14 | 21,828 | $0.64 | $14.0K | 32,617 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 261,900 | — | $0 | 261,900 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-12 | 2024-12-13 | 25,000 | — | $0 | 21,828 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-12 | 2024-12-13 | 25,000 | $12.30 | $307.5K | 6,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-12 | 2024-12-13 | 25,000 | $0.64 | $16.0K | 31,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-11 | 2024-12-13 | 15,000 | — | $0 | 46,828 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-11 | 2024-12-13 | 15,000 | $12.43 | $186.4K | 6,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-11 | 2024-12-13 | 15,000 | $0.64 | $9.6K | 21,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-08-20 | 2024-08-21 | 50,000 | — | $0 | 61,828 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-20 | 2024-08-21 | 50,000 | $15.00 | $750.0K | 6,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-08-20 | 2024-08-21 | 50,000 | $0.64 | $32.0K | 56,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-08-13 | 2024-08-15 | 30,000 | — | $0 | 111,828 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-08-13 | 2024-08-15 | 30,000 | $0.64 | $19.2K | 36,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 30,000 | $13.00 | $390.0K | 6,024 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 350,000 | — | $0 | 350,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 145,000 | — | $0 | 145,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | M Exercise | 2018-08-30 | 2018-09-04 | 81,775 | — | $0 | 159,116 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | F Tax w/h | 2018-08-30 | 2018-09-04 | 43,225 | $0.33 | $14.3K | 115,891 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2018-01-03 | 2018-01-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | F Tax w/h | 2018-01-01 | 2018-01-03 | 5,485 | $1.84 | $10.1K | 159,116 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | F Tax w/h | 2017-09-05 | 2017-09-07 | 14,093 | $1.56 | $22.0K | 164,601 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2017-06-01 | 2017-06-05 | 75,000 | — | $0 | 178,694 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | F Tax w/h | 2017-02-15 | 2017-03-24 | 1,495 | $2.78 | $4.2K | 103,694 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2017-01-05 | 2017-01-06 | 75,000 | — | $0 | 105,189 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-05-20 | 2016-05-20 | 250,000 | — | $0 | 301,891 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-04-25 | 2016-04-27 | 250,000 | — | $0 | 301,891 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-04-25 | 2016-05-20 | 0 | — | $0 | 51,891 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2016-03-15 | 2016-03-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-03-15 | 2016-03-17 | 41,891 | — | $0 | 51,891 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2015-01-29 | 2015-01-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | P Buy | 2014-12-29 | 2014-12-30 | 10,000 | $1.05 | $10.5K | 10,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2014-12-01 | 2014-12-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award | 2014-10-10 | 2014-10-10 | 50,000 | — | $0 | 87,426 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award | 2014-10-10 | 2014-10-10 | 33,333 | — | $0 | 62,426 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award | 2013-04-19 | 2013-04-23 | 50,000 | — | $0 | 63,538 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award | 2013-04-19 | 2013-04-23 | 47,654 | — | $0 | 111,192 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 28,340 | — | $0 | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 1,494 | — | $0 | 52,264 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-11-16 | 2012-11-20 | 30,000 | — | $0 | 50,770 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 15,716 | — | $0 | 166,160 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 15,992 | — | $0 | 150,444 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-01-03 | 2012-01-04 | 9,000 | $0.48 | $4.3K | 134,452 | SEC↗ |